NSC |
Compound |
Enrichment |
Correlation |
NSC 728035 |
1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di |
0.0282295482823984 |
0.12666376 |
NSC 728038 |
2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline |
0.0282295482823984 |
0.25288041 |
NSC 740 |
Methotrexate |
0.0282295482823984 |
0.038136848 |
NSC 747461 |
Null |
0.0282295482823984 |
0.014177032 |
NSC 751152 |
3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone |
0.0282295482823984 |
0.20745644 |
NSC 756404 |
GW843682X |
0.0282295482823984 |
0.14350422 |
NSC 763059 |
Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride |
0.0282295482823984 |
0.032562671 |
NSC 87868 |
2-Phenylethyl isothiocyanate |
0.0282295482823984 |
0.094704761 |
NSC 109834 |
Null |
0.0282295482823988 |
0.19546282 |
NSC 119875 |
Cisplatin |
0.0282295482823988 |
0.067879222 |